BE824665A - 7-(oxo-alcoyl)-1,3-dialcoyl-xanthines, leur procede de preparation et medicaments renfermant ces composes - Google Patents

7-(oxo-alcoyl)-1,3-dialcoyl-xanthines, leur procede de preparation et medicaments renfermant ces composes

Info

Publication number
BE824665A
BE824665A BE152617A BE152617A BE824665A BE 824665 A BE824665 A BE 824665A BE 152617 A BE152617 A BE 152617A BE 152617 A BE152617 A BE 152617A BE 824665 A BE824665 A BE 824665A
Authority
BE
Belgium
Prior art keywords
dialcoyl
xanthins
alcoyl
oxo
compounds
Prior art date
Application number
BE152617A
Other languages
English (en)
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2402908A external-priority patent/DE2402908C2/de
Application filed filed Critical
Publication of BE824665A publication Critical patent/BE824665A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE152617A 1974-01-22 1975-01-22 7-(oxo-alcoyl)-1,3-dialcoyl-xanthines, leur procede de preparation et medicaments renfermant ces composes BE824665A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2402908A DE2402908C2 (de) 1974-01-22 1974-01-22 7-(3-Oxobutyl)-1,3-di-(n-butyl)-xanthin und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
BE824665A true BE824665A (fr) 1975-05-15

Family

ID=5905372

Family Applications (1)

Application Number Title Priority Date Filing Date
BE152617A BE824665A (fr) 1974-01-22 1975-01-22 7-(oxo-alcoyl)-1,3-dialcoyl-xanthines, leur procede de preparation et medicaments renfermant ces composes

Country Status (13)

Country Link
US (2) US4242345A (ja)
JP (1) JPS5912677B2 (ja)
AR (1) AR207462A1 (ja)
AT (1) AT338286B (ja)
BE (1) BE824665A (ja)
CA (1) CA1068693A (ja)
CH (1) CH608236A5 (ja)
FI (1) FI59596C (ja)
FR (1) FR2258183B1 (ja)
GB (1) GB1441562A (ja)
HU (1) HU169012B (ja)
NL (1) NL184330C (ja)
YU (1) YU15175A (ja)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2507555A1 (de) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindung enthaltende arzneimittel
DE2507554A1 (de) * 1975-02-21 1976-09-02 Wuelfing J A Fa 7-(oxoalkyl)-1,3-dialkylxanthine, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE2967632D1 (en) * 1978-04-22 1986-12-04 Beecham Wuelfing Gmbh & Co Kg Use of a xanthine derivate in the manufacture of a medicament
IL59665A0 (en) * 1979-04-05 1980-06-30 Wuelfing J Kg Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions
EP0157098A1 (en) * 1980-06-21 1985-10-09 Beecham Wuelfing GmbH & Co KG Xanthine derivatives, pharmaceuticals compositions containing them and a process for their preparation
GB8418430D0 (en) * 1984-07-19 1984-08-22 Beecham Wuelfing Gmbh & Co Kg Treatment
JPS63225317A (ja) * 1986-10-06 1988-09-20 Hoechst Japan Kk 抗消化性潰瘍剤
US4965271A (en) * 1986-12-31 1990-10-23 Hoechst Roussel Pharmaceuticals, Inc. Method of inhibiting the activity of leukocyte derived cytokines
US5096906A (en) * 1986-12-31 1992-03-17 University Of Virginia Alumni Patents Foundation Method of inhibiting the activity of leukocyte derived cytokines
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤
US5321029A (en) * 1988-11-14 1994-06-14 Beecham-Wuelfing Gmbh & Co.K.G. Xanthines
GB8826595D0 (en) * 1988-11-14 1988-12-21 Beecham Wuelfing Gmbh & Co Kg Active compounds
CA2030112A1 (en) * 1989-11-24 1991-05-25 Yasuo Ito Xanthine compound, method for preparing thereof, and a pharmaceutical composition comprising the same
ATE138266T1 (de) * 1990-11-07 1996-06-15 Hoechst Roussel Pharma Verwendung von xanthinen zur herstellung von arzneimitteln zur hemmung der vermehrung menschlicher retroviren
US6420374B1 (en) 1990-11-30 2002-07-16 Fred Hutchinson Cancer Research Center Use of xanthines as immunosuppressants and to inhibit allograft reactions
MX9203323A (es) * 1991-07-11 1994-07-29 Hoechst Ag El empleo de derivados de xantina para el tratamiento de lesiones secundarias de las celulas nerviosas y trastornos funcionales despues de traumas craneo-cerebrales.
DE59304710D1 (de) * 1992-02-22 1997-01-23 Hoechst Ag Verwendung von Xanthinderivaten zur Behandlung von Muskelschädigungen nach vollständiger Unterbrechung der Blutzirkulation
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US6514949B1 (en) 1994-07-11 2003-02-04 University Of Virginia Patent Foundation Method compositions for treating the inflammatory response
US6448235B1 (en) 1994-07-11 2002-09-10 University Of Virginia Patent Foundation Method for treating restenosis with A2A adenosine receptor agonists
US7427606B2 (en) * 1999-02-01 2008-09-23 University Of Virginia Patent Foundation Method to reduce inflammatory response in transplanted tissue
US7378400B2 (en) * 1999-02-01 2008-05-27 University Of Virginia Patent Foundation Method to reduce an inflammatory response from arthritis
US6232297B1 (en) 1999-02-01 2001-05-15 University Of Virginia Patent Foundation Methods and compositions for treating inflammatory response
US6322771B1 (en) 1999-06-18 2001-11-27 University Of Virginia Patent Foundation Induction of pharmacological stress with adenosine receptor agonists
US6670334B2 (en) 2001-01-05 2003-12-30 University Of Virginia Patent Foundation Method and compositions for treating the inflammatory response
AU2002362443B2 (en) * 2001-10-01 2008-05-15 University Of Virginia Patent Foundation 2-propynyl adenosine analogs having A2A agonist activity and compositions thereof
WO2006023272A1 (en) * 2004-08-02 2006-03-02 University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs having a2a agonist activity
NZ585697A (en) * 2004-08-02 2011-12-22 Univ Virginia Patent Found 2-propynyl adenosine analogs with modified 5'-ribose groups having A2A agonist activity
WO2006028618A1 (en) * 2004-08-02 2006-03-16 University Of Virginia Patent Foundation 2-polycyclic propynyl adenosine analogs with modified 5'-ribose groups having a2a agonist activity
WO2007120972A2 (en) * 2006-02-10 2007-10-25 University Of Virginia Patent Foundation Method to treat sickle cell disease
US8188063B2 (en) 2006-06-19 2012-05-29 University Of Virginia Patent Foundation Use of adenosine A2A modulators to treat spinal cord injury
US8058259B2 (en) 2007-12-20 2011-11-15 University Of Virginia Patent Foundation Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9H-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as A2AR agonists

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2761863A (en) * 1956-09-04 Lower-alkyl
CA557342A (en) 1958-05-13 Doebel Karl Process for the manufacture of novel xanthine derivatives
US2756229A (en) * 1956-07-24 Xanthine derivatives
FR4791E (fr) 1900-06-29 1905-10-16 Eugene Fournier Lampe à pétrole perfectionnée pour chauffage intensif dite: "la naphteuse"
DE926788C (de) 1952-11-07 1955-04-25 Geigy Ag J R Verfahren zur Herstellung von 1, 3-dialkylierten 7-Oxyalkyl-xanthinabkoemmlingen
GB759174A (en) * 1952-11-07 1956-10-17 Geigy Ag J R Improvements in diuretic acting xanthine derivatives
GB759981A (en) * 1953-09-09 1956-10-24 Roche Products Ltd Process for the manufacture of xanthine derivatives
CH325292A (de) 1953-10-21 1957-10-31 Geigy Ag J R Verfahren zur Herstellung von 7-Oxyalkyl-xanthinderivaten
US3737433A (en) * 1964-09-05 1973-06-05 Albert Ag Chem Werke Certain oxoalkyldimethylxanthines
DE2234202A1 (de) 1972-07-12 1974-01-24 Albert Ag Chem Werke Verfahren zur herstellung von oxoalkylxanthinen
DE2330742C2 (de) 1973-06-16 1982-07-29 Hoechst Ag, 6000 Frankfurt 1-(Oxoalkyl)-3-methyl-7-alkylxanthine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2457666A1 (de) * 1974-12-06 1976-06-10 Hoechst Ag Arzneimittel, verfahren zur herstellung von dafuer geeigneten wirkstoffen und diese oxoalkyl-dialkyl-xanthine
JPS5233120A (en) * 1975-09-10 1977-03-14 Nisshin Steel Co Ltd Double coiled automobile steel pipe covered with heat flexible plastic resin

Also Published As

Publication number Publication date
GB1441562A (en) 1976-07-07
HU169012B (ja) 1976-08-28
AT338286B (de) 1977-08-10
NL184330B (nl) 1989-01-16
US4291037A (en) 1981-09-22
NL184330C (nl) 1989-06-16
FR2258183A1 (ja) 1975-08-18
JPS50101386A (ja) 1975-08-11
ATA929674A (de) 1976-12-15
FR2258183B1 (ja) 1978-07-28
YU15175A (en) 1982-06-30
JPS5912677B2 (ja) 1984-03-24
US4242345A (en) 1980-12-30
FI750122A (ja) 1975-07-23
AR207462A1 (es) 1976-10-08
NL7414887A (nl) 1975-07-24
CH608236A5 (ja) 1978-12-29
CA1068693A (en) 1979-12-25
FI59596B (fi) 1981-05-29
FI59596C (fi) 1981-09-10

Similar Documents

Publication Publication Date Title
BE824665A (fr) 7-(oxo-alcoyl)-1,3-dialcoyl-xanthines, leur procede de preparation et medicaments renfermant ces composes
FR2283690A1 (fr) Nouveaux composes tetracycliques utiles comme medicaments et leur procede de preparation
BE829052A (fr) Nouvelles phenylguanidines substituees, leur procede de preparation et medicament les contenant
FR2273546A1 (fr) Nouveaux derives de cephalosporine, leur procede de preparation et medicament les contenant
BE847482A (fr) Nouvelles 4-aminopyrazoles substituees, procede pour leur preparation et medicaments contenant ces composes
BE832124A (fr) Oxo-20 prechames, leur procede de preparation et les medicaments qui en contiennent
FR2305181A1 (fr) Derives de nitrofurylpyrazole, procedes pour leur preparation et medicaments contenant ces composes
FR2287916A1 (fr) Nouveaux derives dipeptidiques, leur procede de preparation et medicament les contenant
BE857289A (fr) 2-benzyl-pyrrolidines, procede pour leur preparation et medicaments contenant ces composes
BE829417A (fr) Nouveaux pyrimidinols, leur procede de preparation et medicament les contenant
BE825623A (fr) Nouvelles cephalosporines, leur procede de preparation et medicament les contenent
FR2290211A1 (fr) Nouveaux 1,1-bioxydes de 4-hydroxy-2h-naphto (2,1-e)-1,2-thiazine-3-carboxamides, leur procede de preparation et medicaments les renfermant
FR2294708A1 (fr) Nouvelles 3-fluoro-2,3-dihydro-1h-1,4-benzodiazepine-2-ones, utiles en tant que medicaments et leur procede de preparation
BE831421A (fr) Nouvelles phenylisothiourees substituees, leur procede de preparation et medicament les contenant
BE794888A (fr) Amides d'acides lysergiques, leur procede de preparation et medicaments contenant ces composes
BE808374A (fr) Nouvelles penicillines, leur procede de preparation et medicament
FR2351994A1 (fr) Composes 9-(5-o-acyl-b-d-arabinofuranosyl)-adeniniques, procede pour leur preparation et application en tant que medicaments
FR2274288A1 (fr) Nouveaux composes arylsulfonylcarbamoyl-1,3-dicarbonyliques, leur procede de preparation et medicament les contenant
FR2322589A1 (fr) Sulfoximides substitues, procede pour leur production et medicaments contenant ces composes
FR2292474A1 (fr) Nouveaux diaryloxy-imidazolyl-o,n-acetals, leur procede de preparation et medicament les contenant
FR2316946A1 (fr) Nouvelles penicillines, leur procede de preparation et medicament les contenant
BE835392A (fr) Nouveaux 1, 1-bioxydes de 4-hydroxy-2hnaphto(2,1-e) -1,2- thiazine - 3 carboxyamides, leur procede de preparation et medicaments les renferment
BE846397A (fr) Nouvelles 2,4-diamino-5-benzyl-pyrimidines, procede pour leur preparation et medicaments contenant ces composes
BE804677A (fr) 3-chloro-2-hydrazonomethyl-4-aza-pentadienne-nitriles substitues, leur procede de preparation et medicaments contenant ces composes
FR2273524A1 (fr) Nouveaux composes aromatiques, leur procede de preparation et medicament les contenant

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: WULFING JOHANN A.

Effective date: 19930131